Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025
Hims & Hers Health, Inc. (NYSE: HIMS) is back in the spotlight. In Thursday’s session on December 4, 2025, the telehealth stock climbed roughly 5–8%, trading around $40 and valuing the company at about $12.8 billion, after a flurry of strategic announcements. Finviz+1 The immediate catalysts: At the same time, fresh coverage from MarketBeat, TipRanks, Zacks and others is revisiting the stock’s valuation, short interest and earnings trajectory. MarketBeat+3MarketBeat+3TipRanks+3 Below is a detailed, news‑driven look at HIMS stock as of December 4, 2025 – including today’s headlines, the latest financials, analyst forecasts, and the key bull and bear arguments. HIMS
